Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 157 clinical trials
Featured trial
Do you suffer from lower back pain?

Do you suffer from lower back pain?

  • 1146 views
  • 08 Nov, 2020
  • 1 location
Featured trial
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of Investigational Product in Patients With Rheumatoid Arthritis (RA) With or Without Background Disease-Modifying Anti-rheumatic Drug (DMARD) Therapy

A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of Investigational Product in Patients With Rheumatoid Arthritis (RA) With or Without Background Disease-Modifying Anti-rheumatic Drug (DMARD) Therapy

  • 195 views
  • 08 Nov, 2020
  • 1 location
None
  • 40 views
  • 26 Nov, 2021
  • 190 locations
None
COVID-19 VACCINE SAFETY AND EFFECTIVENESS

A longitudinal open-label study will include health professionals and patients with immune-mediated inflammatory diseases (IMID) who will receive the ChAdOx1 nCoV-19 vaccine (AZD1222), in a standard 3-dose schedule with an interval of 12 weeks (first-second dose) and 24 weeks (second-thrid dose), in the vaccination campaign against SARS-CoV-2 to assess the …

Accepts healthy volunteers
  • 0 views
  • 28 Nov, 2021
  • 1 location
None
Physiotherapy of Axial Spondyloarthritis

This protocol is for a pragmatic randomised controlled clinical trial (RCT) with a manual spinal mobilisation (MSM) intervention for patients with axial spondyloarthritis (axSpA), embedded in a

  • 0 views
  • 10 Oct, 2021
  • 2 locations
None
Microbiome and Axial Spondyloarthritis

The purpose of this interventional study is to identify the root cause(s) of AxSpA (Axial Spondyloarthritis) relapses, which are likely due to the combination of nutrition, gut microbiome

Accepts healthy volunteers
  • 0 views
  • 29 Oct, 2021
  • 3 locations
None
AScalate: Treat-to-target in Axial Spondyloarthritis

secukinumab as first-line biologic) is superior to a Standard-Of-Care (SOC) approach in terms of achieving strong clinical efficacy in patients with active axial Spondyloarthritis (axSpA) who are nave to

MRI
adalimumab
NSAID
spondylitis
biological therapy
  • 1 views
  • 25 Aug, 2021
  • 44 locations
None
Clinical Trial of TCM Collaborative Care Model in Axial Spondyloarthritis

A pragmatic, prospective, randomized controlled trial will be conducted in patients with axial spondyloarthritis who are NSAID inadequate responders. Patients will be randomized in a 1:1 ratio

prednisolone
NSAID
anti-rheumatic drugs
traditional chinese medicine
DMARD
  • 2 views
  • 26 Jan, 2021
  • 1 location
None
Spondyloarthritis: Inducing Drug-free Remission by Early TNF-alpha Blockade

The SPARTACUS study will explore the therapeutic efficacy of 2 different treatment strategies for patients suffering from peripheral Spondyloarthritis (pSpA), classified according to the

  • 0 views
  • 24 Feb, 2021
  • 6 locations
None
Effects of Nonsteroidal Anti-Inflammatory Drugs in Recurrence of Spondyloarthritis Patients After Remission

The multicenter, randomized controlled trial is to investigate and evaluate the effect of NSAIDs therapy on recurrence in patients with axial spondyloarthritis;

remission
renal function
steroidal anti-inflammatory drugs
NSAID
  • 1 views
  • 25 Jan, 2021
  • 1 location